Virendra Misra, MD
Neurology · Oak Creek, WINPI 1780648048
Payments from drug & device makers
Across 122 payments — averaging $18.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$375
- Otsuka America Pharmaceutical, Inc.$372
- Phathom Pharmaceuticals, Inc.$289
- Vanda Pharmaceuticals Inc.$114
- Lundbeck LLC$100
- Amgen$98
- plus $921 from 21 others
What the payments were for
- Food & beverage$2,268100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 19 | $375 |
| Otsuka America Pharmaceutical, Inc. | 22 | $372 |
| Phathom Pharmaceuticals, Inc. | 26 | $289 |
| Vanda Pharmaceuticals Inc. | 5 | $114 |
| Lundbeck LLC | 5 | $100 |
| Amgen | 3 | $98 |
| Amneal Pharmaceuticals LLC | 5 | $97 |
| Gilead | 1 | $96 |
| Boehringer Ingelheim | 4 | $77 |
| GE HealthCare | 3 | $75 |
| Genentech USA, Inc. | 3 | $74 |
| Teva Pharmaceuticals USA, Inc. | 4 | $73 |
| Novartis | 3 | $69 |
| Tanabe Pharma America, Inc. | 3 | $69 |
| Pfizer | 2 | $40 |
| E.r. Squibb & Sons, L.L.C. | 2 | $34 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Kyowa Kirin, Inc. | 1 | $27 |
| Harmony Biosciences LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Avion Pharmaceuticals | 1 | $17 |
| Novo Nordisk | 1 | $16 |
| Biogen | 1 | $16 |
| UCB, Inc. | 1 | $16 |
| Abbott | 1 | $12 |
How this compares
$2,268 in reported general payments places this provider in the 70th percentile of 308 neurology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AptiomEslicarbazepine Acetate | 18 | $23,573 |
| Memantine Hcl | 65 | $1,819 |
| Divalproex Sodium | 20 | $1,688 |
| Vilazodone Hcl | 18 | $1,637 |
| Carbamazepine ErCarbamazepine | 24 | $1,432 |
| Gabapentin | 82 | $1,331 |
| Oxcarbazepine | 37 | $1,291 |
| Levetiracetam | 60 | $968 |
| Donepezil Hcl | 79 | $709 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 14 | $597 |
| Lamotrigine | 21 | $488 |
| Meclizine Hcl | 19 | $271 |
| Acetazolamide | 13 | $267 |
| Cyclobenzaprine Hcl | 15 | $207 |
| Nortriptyline Hcl | 20 | $192 |
Paid to pharmacies, not to this prescriber.
Other neurology in Oak Creek
- Bhupendra KhatriMilwaukee$7.3M
- Ahmed ObeidatMilwaukee$6M
- James NapierGreen Bay$1.7M
- Malgorzata FranczakMilwaukee$1.7M
- Staley BrodMilwaukee$1.3M
- Daniel LongNeenah$1.2M
- Ankush BhatiaMadison$983K
- Sam HooshmandMilwaukee$783K
- Aaron BubolzGreen Bay$595K
- Christopher LuzzioMadison$555K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.